SNGX יחס מהיר Soligenix Inc

This daily price chart for Soligenix, Inc. (SNGX) reflects the current 2.66. The company's revenues are based on the development of treatments for cutaneous lymphomas and agents for radiation and viral protection. Patent protection and US government contracts create insurmountable barriers for competitors. The integration of thermostable vaccines into national security systems transforms Soligenix, Inc. (SNGX) into a key hub for combating biological threats.

This ratio measures the ability of Soligenix, Inc. (SNGX) to instantaneously settle short-term liabilities using cash and accounts receivable, completely ignoring slow-moving inventories. For Soligenix, Inc. (SNGX), which maintains a staff of biodefense experts through government contracts, this quick liquidity snapshot is critical, as it demonstrates the funding stability of scientific research and protection against cash flow gaps without accounting for the value of warehouse assets.